Nanobiotix
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-06-30 |
|---|---|---|---|
Revenue | $26,638 | $-20,898 | $9,289 |
Gross Profit | 26,638 | -20,898 | 9,289 |
EBITDA | 1,091 | -35,080 | -23,244 |
EBIT | 815 | -36,414 | -23,531 |
Net Income | -5,383 | -46,260 | -21,872 |
Net Change In Cash | 26,638 | -20,898 | 9,289 |
Free Cash Flow | -17,561 | -14,074 | -6,325 |
Cash | 28,818 | 49,737 | 66,335 |
Basic Shares | 47,418 | 47,265 | 47,124 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $-11,609 | $36,208 | $4,776 | $2,647 |
Gross Profit | -11,609 | 36,208 | 3,791 | 2,647 |
EBITDA | -58,324 | -23,686 | -44,217 | -45,605 |
EBIT | -59,945 | -24,237 | -45,717 | -47,165 |
Net Income | -68,132 | -39,700 | -57,043 | -47,004 |
Net Change In Cash | -11,609 | 36,208 | 4,776 | 2,647 |
Free Cash Flow | -20,399 | -12,813 | -37,197 | -30,105 |
Cash | 49,737 | 75,283 | 41,388 | 83,921 |
Basic Shares | 47,265 | 36,928 | 34,851 | 34,733 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | $0 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.98 |
